Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 22
2003 22
2004 23
2005 45
2006 53
2007 54
2008 82
2009 88
2010 92
2011 101
2012 98
2013 155
2014 198
2015 191
2016 233
2017 256
2018 303
2019 361
2020 476
2021 510
2022 620
2023 586
2024 635
2025 781
2026 502

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,801 results

Results by year

Filters applied: . Clear all
Page 1
Gut microbial metabolites in cancer immunomodulation.
Liu H, Xiong X, Zhu W, Wang S, Huang W, Zhu G, Xu H, Yang L. Liu H, et al. Among authors: yang l. Mol Cancer. 2025 Dec 3;25(1):8. doi: 10.1186/s12943-025-02521-5. Mol Cancer. 2025. PMID: 41339918 Free PMC article. Review.
ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.
Shen C, Che Y, Zhou K, Wang K, Li W, Xue D, Wu T, Yang L, Chen M, Sheng Y, Zhang C, Robinson S, Chen H, Sau L, Chen Z, Wunderlich M, Han L, Tang T, Qing Y, Wu D, Sun M, Leung K, Dąbrowska K, Pirrotte P, Hu YC, Ghoda LY, Zhang B, Mulloy JC, Wei M, Marcucci G, He C, Deng X, Chen J. Shen C, et al. Among authors: yang l. Cancer Discov. 2025 Nov 3;15(11):2298-2325. doi: 10.1158/2159-8290.CD-24-1043. Cancer Discov. 2025. PMID: 40747882 Free PMC article.
DDX6 undergoes phase separation to modulate metabolic plasticity and chemoresistance.
Bi H, Li W, Ren L, Zhang H, Dong L, Chan A, Wang X, Yang L, Zhang X, Xue M, Qin H, Wu X, Hoeve-Scott JT, Zhang B, Li L, Wunderlich M, Mulloy JC, Rosen ST, Chen J, Li X, Chen CW, Su R. Bi H, et al. Among authors: yang l. Nat Commun. 2025 Dec 2;17(1):260. doi: 10.1038/s41467-025-66966-4. Nat Commun. 2025. PMID: 41330929 Free PMC article.
Artificial Nervous Systems.
Yang L, Cheng Q, Li Y, Wu N, Xu Z, Xu W. Yang L, et al. Adv Sci (Weinh). 2025 Oct;12(40):e11478. doi: 10.1002/advs.202511478. Epub 2025 Sep 14. Adv Sci (Weinh). 2025. PMID: 40946192 Free PMC article. Review.
Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial.
Wu X, Quan D, Li W, Wisskirchen K, Wu W, Zhou Y, Liu YP, Wan X, Wang X, Zhang X, Yang L, Zheng M, Zhang K, Protzer U, Du S, Qu X. Wu X, et al. Among authors: yang l. Gut. 2025 Dec 5;75(1):147-160. doi: 10.1136/gutjnl-2025-335456. Gut. 2025. PMID: 40803751 Free PMC article. Clinical Trial.
5,801 results